EP3313427A4 - Therapeutic peptides and methods of use thereof - Google Patents

Therapeutic peptides and methods of use thereof Download PDF

Info

Publication number
EP3313427A4
EP3313427A4 EP16815459.9A EP16815459A EP3313427A4 EP 3313427 A4 EP3313427 A4 EP 3313427A4 EP 16815459 A EP16815459 A EP 16815459A EP 3313427 A4 EP3313427 A4 EP 3313427A4
Authority
EP
European Patent Office
Prior art keywords
methods
therapeutic peptides
peptides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16815459.9A
Other languages
German (de)
French (fr)
Other versions
EP3313427A2 (en
Inventor
James Olson
Andrew David STRAND
Emily June GIRARD
Roland STRONG
Christopher Mehlin
Colin CORRENTI
Andrew James MHYRE
Mi-youn BRUSNIAK
Theo SOTTERO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Priority claimed from PCT/US2016/039431 external-priority patent/WO2016210376A2/en
Publication of EP3313427A2 publication Critical patent/EP3313427A2/en
Publication of EP3313427A4 publication Critical patent/EP3313427A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP16815459.9A 2015-06-26 2016-06-24 Therapeutic peptides and methods of use thereof Withdrawn EP3313427A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562185527P 2015-06-26 2015-06-26
US201562185529P 2015-06-26 2015-06-26
US201562239743P 2015-10-09 2015-10-09
US201562239739P 2015-10-09 2015-10-09
US201662322724P 2016-04-14 2016-04-14
PCT/US2016/039431 WO2016210376A2 (en) 2015-06-26 2016-06-24 Therapeutic peptides and methods of use thereof

Publications (2)

Publication Number Publication Date
EP3313427A2 EP3313427A2 (en) 2018-05-02
EP3313427A4 true EP3313427A4 (en) 2018-12-26

Family

ID=61661067

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16815459.9A Withdrawn EP3313427A4 (en) 2015-06-26 2016-06-24 Therapeutic peptides and methods of use thereof

Country Status (2)

Country Link
EP (1) EP3313427A4 (en)
CN (1) CN107847554A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020068815A1 (en) * 2018-09-25 2020-04-02 Emory University Nucleic acids for cell recognition and integration
TWI715927B (en) * 2019-02-01 2021-01-11 國立清華大學 Use of composition for manufacturing a medicine for treating cancer cells
CN112028981B (en) * 2020-09-08 2022-03-15 湖州眺旺生物科技有限公司 Recombinant white high-foot spider toxin polypeptide and preparation method thereof
CN114031678A (en) * 2021-12-08 2022-02-11 中国科学院新疆理化技术研究所 Preparation method and application of polypeptide component of scorpion venom polypeptide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012064658A1 (en) * 2010-11-08 2012-05-18 The Board Of Trustees Of The Leland Stanford Junior University Fusion proteins comprising an engineered knottin peptide and uses thereof
US20130280281A1 (en) * 2010-07-02 2013-10-24 Jean-Paul Castaigne Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
WO2014063012A1 (en) * 2012-10-19 2014-04-24 The Board Of Trustees Of The Leland Stanford Junior University Conjugated knottin mini-proteins containing non-natural amino acids
WO2014093406A1 (en) * 2012-12-10 2014-06-19 Fred Hutchinson Cancer Research Center Methods for screening
WO2017100700A2 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1788017B (en) * 2003-02-10 2013-04-24 to-BBB控股股份有限公司 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
CN102174080B (en) * 2010-09-19 2014-07-09 复旦大学 Polypeptide with brain targeted medicine delivery characteristic and preparation method thereof
CN103083689B (en) * 2011-11-01 2016-08-03 复旦大学 A kind of for brain tumor diagnosis across the multi-modal Nano medication of blood brain barrier targeting
EP3046572A4 (en) * 2013-09-17 2017-06-28 Blaze Bioscience, Inc. Chlorotoxin conjugates and methods of use thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280281A1 (en) * 2010-07-02 2013-10-24 Jean-Paul Castaigne Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
WO2012064658A1 (en) * 2010-11-08 2012-05-18 The Board Of Trustees Of The Leland Stanford Junior University Fusion proteins comprising an engineered knottin peptide and uses thereof
WO2014063012A1 (en) * 2012-10-19 2014-04-24 The Board Of Trustees Of The Leland Stanford Junior University Conjugated knottin mini-proteins containing non-natural amino acids
WO2014093406A1 (en) * 2012-12-10 2014-06-19 Fred Hutchinson Cancer Research Center Methods for screening
WO2017100700A2 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 10 August 2017 (2017-08-10), "Pharmaceutical composition preparing knotted peptide, SEQ ID 41.", retrieved from EBI accession no. GSP:BDZ69828 Database accession no. BDZ69828 *
DATABASE Geneseq [online] 31 July 2014 (2014-07-31), "Chlorotoxin (CTX) peptide variant, SEQ 39.", retrieved from EBI accession no. GSP:BBI66026 Database accession no. BBI66026 *
DATABASE Geneseq [online] 31 July 2014 (2014-07-31), "Chlorotoxin (CTX) peptide variant, SEQ 44.", retrieved from EBI accession no. GSP:BBI66031 Database accession no. BBI66031 *

Also Published As

Publication number Publication date
CN107847554A (en) 2018-03-27
EP3313427A2 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
EP3509615A4 (en) Stable peptides and methods of use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3328419A4 (en) Pd-1-binding molecules and methods of use thereof
EP3303634A4 (en) Cas9 variants and methods of use thereof
EP3302562A4 (en) Lag-3-binding molecules and methods of use thereof
EP3359168A4 (en) Therapeutic compounds and methods
EP3209681A4 (en) Pharmaceutical compositions comprising peptide variants and methods of use thereof
IL256515A (en) Therapeutic peptides and methods of use thereof
EP3097122A4 (en) Binding proteins and methods of use thereof
EP3177638A4 (en) Targeting peptides and methods of use
EP3131566A4 (en) Bi-terminal pegylated integrin-binding peptides and methods of use thereof
EP3220953A4 (en) COMPOSITIONS AND METHODS OF USING THERAPEUTIC p53 PEPTIDES AND ANALOGUES
EP3394098A4 (en) Anti-myostatin antibodies and methods of use
EP3274472A4 (en) Antimicrobial peptides and methods of use thereof
EP3116898A4 (en) Use of aav-expressed m013 protein as an anti-inflammatory therapeutic
EP3526205A4 (en) Therapeutic compounds and methods of use thereof
EP3525855A4 (en) Inhaler and methods of use thereof
EP3389705A4 (en) Listeria-based immunotherapy and methods of use thereof
EP3265476A4 (en) Protoxin-ii variants and methods of use
EP3380525A4 (en) Pharmaceutical formulations and methods of use thereof
EP3172224A4 (en) Factor h binding protein variants and methods of use thereof
EP3270918A4 (en) Anti-met antibodies and methods of use thereof
EP3277304A4 (en) Protoxin-ii variants and methods of use
EP3215172A4 (en) Modifications and uses of conotoxin peptides
EP3285805A4 (en) Therapeutic antibodies and uses thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171208

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20181128

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/16 20060101AFI20181123BHEP

Ipc: A61K 49/14 20060101ALI20181123BHEP

Ipc: A61K 38/00 20060101ALI20181123BHEP

Ipc: C07K 14/435 20060101ALI20181123BHEP

Ipc: A61K 38/03 20060101ALI20181123BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20191108

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210202